UGSE: QCIL Company Description
Quality Chemical Industries Limited, a pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda.
It offers antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics, and antidiabetics products; and Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection.
The company also offers Lumartem/Lumet tablets for the treatment of malaria; Texavir and Zentair for the treatment of Hepatitis B; and Isoniazid/Pyridoxine Hydrochloride /Sulfamethoxazole Trimethoprim tablets for the treatment of tuberculosis.
In addition, it provides Emeset for the treatment of nausea and vomiting; Ciplox and Azicip, anti-infectives to prevent and treat infections; Amlopres to treat hypertension; and Erecto for the treatment of reproductive disorders, such as erectile dysfunction.
It exports its products to approximately 13 countries in Africa. The company was formerly known as Cipla Quality Chemical Industries Limited and changed its name to Quality Chemical Industries Limited in February 2024.
The company was incorporated in 2005 and is based in Kampala, Uganda. Quality Chemical Industries Limited is a subsidiary of Cipla Limited.
Country | Uganda |
Founded | 2005 |
Industry | Pharmaceutical Preparations |
Employees | 362 |
CEO | Ajay Pal |
Contact Details
Address: Luzira Industrial Park Kampala Uganda | |
Phone | 256 312 341100 |
Website | qcil.com |
Stock Details
Ticker Symbol | QCIL |
Exchange | Uganda Securities Exchange |
Fiscal Year | April - March |
Reporting Currency | UGX |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Ajay Pal | Chief Executive Officer |
Frederick Kakooza | Chief Financial Officer |
Panda Ramakanta | Chief Operating Officer |